{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T11:45:40Z","timestamp":1792842340541,"version":"4.5.0"},"reference-count":200,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T00:00:00Z","timestamp":1711584000000},"content-version":"am","delay-in-days":393,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.lpm.2023.104164","type":"journal-article","created":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T02:49:11Z","timestamp":1679971751000},"page":"104164","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Lower-limb peripheral arterial disease and amputations in people with diabetes: Risk factors, prognostic value and management"],"prefix":"10.1016","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1317-5662","authenticated-orcid":false,"given":"Ninon","family":"Foussard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loubna","family":"Dari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Ducasse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Rigalleau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6139-1197","authenticated-orcid":false,"given":"Kamel","family":"Mohammedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5340-1831","authenticated-orcid":false,"given":"Caroline","family":"Caradu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lpm.2023.104164_bib0001","article-title":"Burden of peripheral artery disease and its attributable risk factors in 204 countries and territories from 1990 to 2019","volume":"9","author":"Lin","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.lpm.2023.104164_bib0002","doi-asserted-by":"crossref","first-page":"h4865","DOI":"10.1136\/bmj.h4865","article-title":"Usual blood pressure, peripheral arterial disease, and vascular risk: cohort study of 4.2 million adults","author":"Emdin","year":"2015","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.lpm.2023.104164_bib0003","doi-asserted-by":"crossref","first-page":"42S","DOI":"10.1016\/j.jvs.2014.12.008","article-title":"A systematic review for the screening for peripheral arterial disease in asymptomatic patients","volume":"61","author":"Alahdab","year":"2015","journal-title":"J Vasc Surg"},{"issue":"6","key":"10.1016\/j.lpm.2023.104164_bib0004","doi-asserted-by":"crossref","first-page":"738\u201143","DOI":"10.1161\/01.CIR.0000137913.26087.F0","article-title":"Prevalence of and risk factors for peripheral arterial disease in the united states: results from the national health and nutrition examination survey, 1999\u20132000","volume":"110","author":"Selvin","year":"2004","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.lpm.2023.104164_bib0005","doi-asserted-by":"crossref","first-page":"e1020\u201130","DOI":"10.1016\/S2214-109X(19)30255-4","article-title":"Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis","volume":"7","author":"Song","year":"2019","journal-title":"Lancet Glob Health"},{"issue":"1","key":"10.1016\/j.lpm.2023.104164_bib0006","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s12933-020-01130-4","article-title":"Diabetes as a risk factor for incident peripheral arterial disease in women compared to men: a systematic review and meta-analysis","volume":"19","author":"Chase-Vilchez","year":"2020","journal-title":"Cardiovasc Diabetol"},{"issue":"5","key":"10.1016\/j.lpm.2023.104164_bib0007","doi-asserted-by":"crossref","first-page":"1291\u20119","DOI":"10.1016\/j.jvs.2013.11.063","article-title":"Mortality rates and mortality predictors in patients with symptomatic peripheral artery disease stratified according to age and diabetes","volume":"59","author":"Mueller","year":"2014","journal-title":"J Vasc Surg"},{"issue":"3","key":"10.1016\/j.lpm.2023.104164_bib0008","doi-asserted-by":"crossref","first-page":"575\u201180","DOI":"10.2337\/diacare.29.03.06.dc05-1567","article-title":"Peripheral arterial disease and risk of cardiac death in type 2 diabetes","volume":"29","author":"Norman","year":"2006","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.lpm.2023.104164_bib0009","doi-asserted-by":"crossref","first-page":"318\u201130","DOI":"10.1177\/00033197211042494","article-title":"Adverse prognosis of peripheral artery disease treatments associated with diabetes: a comprehensive meta-analysis","volume":"73","author":"Luan","year":"2022","journal-title":"Angiology"},{"issue":"1","key":"10.1016\/j.lpm.2023.104164_bib0010","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2020-001803","article-title":"Peripheral artery disease, lower limb revascularization, and amputation in diabetes patients with and without coronary artery disease: a cohort study from the Western Denmark Heart Registry","volume":"9","author":"Olesen","year":"2021","journal-title":"BMJ Open Diab Res Care"},{"issue":"5","key":"10.1016\/j.lpm.2023.104164_bib0011","doi-asserted-by":"crossref","first-page":"894\u20119","DOI":"10.2337\/diacare.25.5.894","article-title":"UKPDS 59: hyperglycemia and other potentially modifiable risk factors for peripheral vascular disease in type 2 diabetes","volume":"25","author":"Adler","year":"2002","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.lpm.2023.104164_bib0012","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12933-020-01198-y","article-title":"History of lower-limb complications and risk of cancer death in people with type 2 diabetes","volume":"20","author":"Mohammedi","year":"2021","journal-title":"Cardiovasc Diabetol"},{"issue":"10","key":"10.1016\/j.lpm.2023.104164_bib0013","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.2337\/dc16-0588","article-title":"Microvascular and macrovascular disease and risk for major peripheral arterial disease in patients with type 2 diabetes","volume":"39","author":"Mohammedi","year":"2016","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.lpm.2023.104164_bib0014","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1001\/jamasurg.2014.1007","article-title":"Fifteen-year trends in lower limb amputation, revascularization, and preventive measures among medicare patients","volume":"150","author":"Goodney","year":"2015","journal-title":"JAMA Surg"},{"issue":"5","key":"10.1016\/j.lpm.2023.104164_bib0015","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.ejvs.2019.06.007","article-title":"Major amputation rates in patients with peripheral arterial disease aged 50 years and over in denmark during the period 1997\u20132014 and their relationship with demographics, risk factors, and vascular services","volume":"58","author":"Londero","year":"2019","journal-title":"Eur J Vasc Endovasc Sur"},{"issue":"16","key":"10.1016\/j.lpm.2023.104164_bib0016","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/j.jacc.2016.02.040","article-title":"Nationwide trends of hospital admission and outcomes among critical limb ischemia patients","volume":"67","author":"Agarwal","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.lpm.2023.104164_bib0017","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2337\/dc18-1380","article-title":"resurgence of diabetes-related nontraumatic lower-extremity amputation in the young and middle-aged adult U.S. population","volume":"42","author":"Geiss","year":"2019","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.lpm.2023.104164_bib0018","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12933-021-01441-0","article-title":"Diabetes and other vascular risk factors in association with the risk of lower extremity amputation in chronic limb-threatening ischemia: a prospective cohort study","volume":"21","author":"Ying","year":"2022","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"10.1016\/j.lpm.2023.104164_bib0019","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.ejvs.2015.10.022","article-title":"The risk of disease progression in peripheral arterial disease is higher than expected: a meta-analysis of mortality and disease progression in peripheral arterial disease","volume":"51","author":"Sigvant","year":"2016","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.lpm.2023.104164_bib0020","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.atherosclerosis.2019.09.012","article-title":"Morbidity and mortality associated with atherosclerotic peripheral artery disease: a systematic review","volume":"293","author":"Agnelli","year":"2020","journal-title":"Atherosclerosis"},{"issue":"11","key":"10.1016\/j.lpm.2023.104164_bib0021","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.025504","article-title":"Total cardiovascular and limb events and the impact of polyvascular disease in chronic symptomatic peripheral artery disease","volume":"11","author":"Szarek","year":"2022","journal-title":"JAHA"},{"issue":"2","key":"10.1016\/j.lpm.2023.104164_bib0022","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1001\/jama.300.2.197","article-title":"Ankle brachial index combined with framingham risk score to predict cardiovascular events and mortality: a meta-analysis","volume":"300","year":"2008","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.lpm.2023.104164_bib0023","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.gheart.2013.12.008","article-title":"Global and regional burden of death and disability from peripheral artery disease: 21 world regions, 1990 to 2010","volume":"9","author":"Sampson","year":"2014","journal-title":"gh"},{"issue":"2","key":"10.1016\/j.lpm.2023.104164_bib0024","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1053\/j.tvir.2016.04.001","article-title":"Epidemiology of peripheral arterial disease and critical limb ischemia","volume":"19","author":"Dua","year":"2016","journal-title":"Tech Vasc Interv Radiol"},{"key":"10.1016\/j.lpm.2023.104164_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpsychores.2020.109963","article-title":"Mental health concerns in patients with symptomatic peripheral artery disease: insights from the PORTRAIT registry","volume":"131","author":"Thomas","year":"2020","journal-title":"J Psychosom Res"},{"issue":"1","key":"10.1016\/j.lpm.2023.104164_bib0026","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.004519","article-title":"Lower extremity peripheral artery disease and quality of life among older individuals in the community","volume":"6","author":"Wu","year":"2017","journal-title":"JAHA"},{"issue":"2","key":"10.1016\/j.lpm.2023.104164_bib0027","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ejvs.2011.09.016","article-title":"Two-year vascular hospitalisation rates and associated costs in patients at risk of atherothrombosis in france and germany: highest burden for peripheral arterial disease","volume":"43","author":"Smolderen","year":"2012","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.lpm.2023.104164_bib0028","unstructured":"Yost ML - For The Sage Group. The Cost of Critical Limb Ischemia. https:\/\/www.thesagegroup.us\/reports\/the-cost-of-critical-limb-ischemia\/"},{"issue":"4","key":"10.1016\/j.lpm.2023.104164_bib0029","doi-asserted-by":"crossref","first-page":"435","DOI":"10.23736\/S0021-9509.19.10936-6","article-title":"The burden of amputation in patients with peripheral arterial disease in the Netherlands","volume":"61","author":"Spoorendonk","year":"2020","journal-title":"J Cardiovasc Surg"},{"issue":"1","key":"10.1016\/j.lpm.2023.104164_bib0030","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s00125-006-0491-1","article-title":"High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study","volume":"50","author":"Prompers","year":"2007","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.lpm.2023.104164_bib0031","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s12933-016-0446-x","article-title":"Presentations of major peripheral arterial disease and risk of major outcomes in patients with type 2 diabetes: results from the ADVANCE-ON study","volume":"15","author":"Mohammedi","year":"2016","journal-title":"Cardiovasc Diabetol"},{"issue":"12","key":"10.1016\/j.lpm.2023.104164_bib0032","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.2337\/dc16-1594","article-title":"Absence of peripheral pulses and risk of major vascular outcomes in patients with type 2 diabetes","volume":"39","author":"Mohammedi","year":"2016","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.lpm.2023.104164_bib0033","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2020-001355","article-title":"Survival and factors predicting mortality after major and minor lower-extremity amputations among patients with diabetes: a population-based study using health information systems","volume":"8","author":"Cascini","year":"2020","journal-title":"BMJ Open Diab Res Care"},{"issue":"1","key":"10.1016\/j.lpm.2023.104164_bib0034","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12933-022-01487-8","article-title":"Differential prognostic burden of cardiovascular disease and lower-limb amputation on the risk of all-cause death in people with long-standing type 1 diabetes","volume":"21","author":"Camoin","year":"2022","journal-title":"Cardiovasc Diabetol"},{"issue":"5","key":"10.1016\/j.lpm.2023.104164_bib0035","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.2337\/dc13-2303","article-title":"Risk factors for incident peripheral arterial disease in type 2 diabetes: results from the bypass angioplasty revascularization investigation in type 2 diabetes (BARI 2D) trial","volume":"37","author":"Althouse","year":"2014","journal-title":"Diabetes Care"},{"issue":"21","key":"10.1016\/j.lpm.2023.104164_bib0036","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1161\/CIRCULATIONAHA.118.035432","article-title":"Lipoprotein particle profiles, standard lipids, and peripheral artery disease incidence: prospective data from the women's health study","volume":"138","author":"Aday","year":"2018","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.lpm.2023.104164_bib0037","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1053\/j.ajkd.2019.08.028","article-title":"Peripheral artery disease: its adverse consequences with and without CKD","volume":"75","author":"Bourrier","year":"2020","journal-title":"Am J Kidney Dis"},{"issue":"10","key":"10.1016\/j.lpm.2023.104164_bib0038","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.2337\/dc18-0695","article-title":"Prognostic values of inflammatory and redox status biomarkers on the risk of major lower-extremity artery disease in individuals with type 2 diabetes","volume":"41","author":"Nativel","year":"2018","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.lpm.2023.104164_bib0039","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/S2213-8587(17)30183-3","article-title":"Measures of chronic kidney disease and risk of incident peripheral artery disease: a collaborative meta-analysis of individual participant data","volume":"5","author":"Matsushita","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"11","key":"10.1016\/j.lpm.2023.104164_bib0040","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.2337\/dc20-1085","article-title":"Relationship between diabetic retinopathy stages and risk of major lower-extremity arterial disease in patients with type 2 diabetes","volume":"43","author":"Foussard","year":"2020","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.lpm.2023.104164_bib0041","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1136\/heartjnl-2013-303605","article-title":"Paradoxically lower prevalence of peripheral arterial disease in South Asians: a systematic review and meta-analysis","volume":"100","author":"Sebastianski","year":"2014","journal-title":"Heart"},{"issue":"4","key":"10.1016\/j.lpm.2023.104164_bib0042","doi-asserted-by":"crossref","first-page":"828","DOI":"10.2337\/dc19-0973","article-title":"Leukocyte telomere length, DNA oxidation, and risk of lower-extremity amputation in patients with long-standing type 1 diabetes","volume":"43","author":"Sanchez","year":"2020","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.lpm.2023.104164_bib0043","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2337\/dc21-0973","article-title":"Association between the ACE insertion\/deletion polymorphism and risk of lower-limb amputation in patients with long-standing type 1 diabetes","volume":"45","author":"Mohammedi","year":"2022","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.lpm.2023.104164_bib0044","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/eurjcn\/zvaa022","article-title":"Risk factors associated with amputation-free survival for patients with peripheral arterial disease: a systematic review","volume":"20","author":"Kim","year":"2021","journal-title":"Eur J Cardiovasc Nurs"},{"issue":"3","key":"10.1016\/j.lpm.2023.104164_bib0045","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1007\/s00125-020-05326-x","article-title":"Plasma concentrations of lipoproteins and risk of lower-limb peripheral artery disease in people with type 2 diabetes: the SURDIAGENE study","volume":"64","author":"Bertrand","year":"2021","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.lpm.2023.104164_bib0046","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.33953","article-title":"Temporal trends in incidence rates of lower extremity amputation and associated risk factors among patients using veterans health administration services from 2008 to 2018","volume":"4","author":"Cai","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"7","key":"10.1016\/j.lpm.2023.104164_bib0047","article-title":"Incidence and factors associated with major amputation in patients with peripheral artery disease: insights from the EUCLID trial","volume":"13","author":"Long","year":"2020","journal-title":"Circ"},{"issue":"6","key":"10.1016\/j.lpm.2023.104164_bib0048","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1161\/CIRCULATIONAHA.119.040672","article-title":"Microvascular disease, peripheral artery disease, and amputation","volume":"140","author":"Beckman","year":"2019","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.lpm.2023.104164_bib0049","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007425","article-title":"Race and socioeconomic status independently affect risk of major amputation in peripheral artery disease","volume":"7","author":"Arya","year":"2018","journal-title":"JAHA"},{"issue":"9","key":"10.1016\/j.lpm.2023.104164_bib0050","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.jacc.2018.06.041","article-title":"Major adverse limb events and 1-year outcomes after peripheral artery revascularization","volume":"72","author":"Hess","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"18","key":"10.1016\/j.lpm.2023.104164_bib0051","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2017.02.064","article-title":"Underuse of prevention and lifestyle counseling in patients with peripheral artery disease","volume":"69","author":"Berger","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.lpm.2023.104164_bib0052","first-page":"1","article-title":"ESVM Guideline on peripheral arterial disease","volume":"48","author":"Frank","year":"2019","journal-title":"J Vasc Dis"},{"issue":"3","key":"10.1016\/j.lpm.2023.104164_bib0053","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.jvs.2019.05.050","article-title":"Critical analysis and limitations of resting ankle-brachial index in the diagnosis of symptomatic peripheral arterial disease patients and the role of diabetes mellitus and chronic kidney disease","volume":"71","author":"AbuRahma","year":"2020","journal-title":"J Vasc Surg"},{"issue":"2","key":"10.1016\/j.lpm.2023.104164_bib0054","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/eurheartj\/ehz486","article-title":"2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD","volume":"41","author":"Cosentino","year":"2020","journal-title":"Eur Heart J"},{"issue":"6S","key":"10.1016\/j.lpm.2023.104164_bib0055","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.1016\/j.jvs.2019.02.016","article-title":"Global vascular guidelines on the management of chronic limb-threatening ischemia","volume":"69","author":"Conte","year":"2019","journal-title":"J Vasc Surg"},{"issue":"4","key":"10.1016\/j.lpm.2023.104164_bib0056","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.ejvs.2010.06.008","article-title":"Validation of a fully automatic photoplethysmographic device for toe blood pressure measurement","volume":"40","author":"P\u00e9rez-Martin","year":"2010","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"6","key":"10.1016\/j.lpm.2023.104164_bib0057","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1177\/00033197211063657","article-title":"Toe pressure measurements in patients suspected of critical limb ischemia","volume":"73","author":"Dari","year":"2022","journal-title":"Angiology"},{"issue":"5","key":"10.1016\/j.lpm.2023.104164_bib0058","first-page":"560","article-title":"Canadian cardiovascular society 2022 guidelines for peripheral arterial disease","volume":"38","author":"Abramson","year":"2022","journal-title":"Can J Cardiol"},{"issue":"3","key":"10.1016\/j.lpm.2023.104164_bib0059","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1177\/0003319718793566","article-title":"Comparison of ankle pressure, systolic toe pressure, and transcutaneous oxygen pressure to predict major amputation after 1 year in the COPART Cohort","volume":"70","author":"Salaun","year":"2019","journal-title":"Angiology"},{"issue":"3","key":"10.1016\/j.lpm.2023.104164_bib0060","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ejvs.2011.12.004","article-title":"The use of transcutaneous oximetry to predict healing complications of lower limb amputations: a systematic review and meta-analysis","volume":"43","author":"Arsenault","year":"2012","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"1","key":"10.1016\/j.lpm.2023.104164_bib0061","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0033-8389(22)00563-2","article-title":"Peripheral arterial disease. Evaluation with color flow and duplex sonography","volume":"33","author":"Polak","year":"1995","journal-title":"Radiol Clin North Am"},{"issue":"5","key":"10.1016\/j.lpm.2023.104164_bib0062","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1002\/jum.14451","article-title":"Prospects of contrast-enhanced ultrasonography for the diagnosis of peripheral arterial disease: a meta-analysis","volume":"37","author":"xia","year":"2018","journal-title":"J Ultrasound Med"},{"issue":"9","key":"10.1016\/j.lpm.2023.104164_bib0063","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.3390\/jcm11092547","article-title":"Major adverse events in patients with peripheral artery disease after endovascular revascularization: a retrospective study","volume":"11","author":"Kim","year":"2022","journal-title":"J Clin Med"},{"issue":"9131","key":"10.1016\/j.lpm.2023.104164_bib0064","first-page":"837","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)","volume":"352","year":"1998","journal-title":"Lancet North Am Ed"},{"issue":"24","key":"10.1016\/j.lpm.2023.104164_bib0065","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes","volume":"358","author":"Patel","year":"2008","journal-title":"N Engl J Med"},{"issue":"7258","key":"10.1016\/j.lpm.2023.104164_bib0066","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/bmj.321.7258.405","article-title":"Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study","volume":"321","author":"Stratton","year":"2000","journal-title":"BMJ"},{"issue":"15","key":"10.1016\/j.lpm.2023.104164_bib0067","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-Year follow-up of intensive glucose control in type 2 diabetes","volume":"359","author":"Holman","year":"2008","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.lpm.2023.104164_bib0068","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.jamcollsurg.2018.09.021","article-title":"Effect of intensive glycemic control on risk of lower extremity amputation","volume":"227","author":"Goldman","year":"2018","journal-title":"J Am Coll Surg"},{"issue":"2","key":"10.1016\/j.lpm.2023.104164_bib0069","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJMoa0808431","article-title":"Glucose control and vascular complications in veterans with type 2 diabetes","volume":"360","author":"Duckworth","year":"2009","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1016\/j.lpm.2023.104164_bib0070","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1056\/NEJMoa1806802","article-title":"Intensive glucose control in patients with type 2 diabetes \u2014 15-year follow-up","volume":"380","author":"Reaven","year":"2019","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.lpm.2023.104164_bib0071","doi-asserted-by":"crossref","first-page":"22S","DOI":"10.1016\/j.jvs.2015.10.005","article-title":"A systematic review and meta-analysis of glycemic control for the prevention of diabetic foot syndrome","volume":"63","author":"Hasan","year":"2016","journal-title":"J Vasc Surg"},{"issue":"9493","key":"10.1016\/j.lpm.2023.104164_bib0072","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/S0140-6736(05)67528-9","article-title":"Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial","volume":"366","author":"Dormandy","year":"2005","journal-title":"Lancet North Am Ed"},{"issue":"3","key":"10.1016\/j.lpm.2023.104164_bib0073","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/dom.12608","article-title":"Ten-year observational follow-up of PROactive: a randomized cardiovascular outcomes trial evaluating pioglitazone in type 2 diabetes","volume":"18","author":"Erdmann","year":"2016","journal-title":"Diabetes Obes Metab"},{"issue":"10","key":"10.1016\/j.lpm.2023.104164_bib0074","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.2337\/dc12-2265","article-title":"Favorable effects of insulin sensitizers pertinent to peripheral arterial disease in type 2 diabetes","volume":"36","author":"Althouse","year":"2013","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.lpm.2023.104164_bib0075","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12933-017-0509-7","article-title":"Association between metformin use and below-the-knee arterial calcification score in type 2 diabetic patients","volume":"16","author":"Mary","year":"2017","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"10.1016\/j.lpm.2023.104164_bib0076","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1056\/NEJMoa1501352","article-title":"Effect of sitagliptin on cardiovascular outcomes in type 2 diabetes","volume":"373","author":"Green","year":"2015","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1016\/j.lpm.2023.104164_bib0077","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1056\/NEJMoa1509225","article-title":"Lixisenatide in patients with type 2 diabetes and acute coronary syndrome","volume":"373","author":"Pfeffer","year":"2015","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.lpm.2023.104164_bib0078","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N Engl J Med"},{"issue":"19","key":"10.1016\/j.lpm.2023.104164_bib0079","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.lpm.2023.104164_bib0080","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.lpm.2023.104164_bib0081","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJMoa1611925","article-title":"Canagliflozin and cardiovascular and renal events in type 2 diabetes","volume":"377","author":"Neal","year":"2017","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.lpm.2023.104164_bib0082","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJMoa1812389","article-title":"Dapagliflozin and cardiovascular outcomes in type 2 diabetes","volume":"380","author":"Wiviott","year":"2019","journal-title":"N Engl J Med"},{"issue":"10193","key":"10.1016\/j.lpm.2023.104164_bib0083","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0140-6736(19)31149-3","article-title":"Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial","volume":"394","author":"Gerstein","year":"2019","journal-title":"Lancet North Am Ed"},{"issue":"10","key":"10.1016\/j.lpm.2023.104164_bib0084","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.2337\/dc18-1094","article-title":"The Impact of liraglutide on diabetes-related foot ulceration and associated complications in patients with type 2 diabetes at high risk for cardiovascular events: results From the LEADER trial","volume":"41","author":"Dhatariya","year":"2018","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.lpm.2023.104164_bib0085","article-title":"Clinical outcomes in patients with type 2 diabetes mellitus and peripheral artery disease: results from the EXSCEL trial","volume":"12","author":"Badjatiya","year":"2019","journal-title":"Circ"},{"issue":"9","key":"10.1016\/j.lpm.2023.104164_bib0086","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1007\/s00125-021-05497-1","article-title":"Major adverse cardiovascular and limb events in patients with diabetes treated with GLP-1 receptor agonists vs DPP-4 inhibitors","volume":"64","author":"Lin","year":"2021","journal-title":"Diabetologia"},{"issue":"10313","key":"10.1016\/j.lpm.2023.104164_bib0087","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/S0140-6736(21)02188-7","article-title":"Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial","volume":"398","author":"Del Prato","year":"2021","journal-title":"Lancet North Am Ed"},{"issue":"4","key":"10.1016\/j.lpm.2023.104164_bib0088","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1161\/CIRCULATIONAHA.117.032038","article-title":"Canagliflozin for primary and secondary prevention of cardiovascular events: results from the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)","volume":"137","author":"Mahaffey","year":"2018","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.lpm.2023.104164_bib0089","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1007\/s00125-019-4839-8","article-title":"Effects of canagliflozin on amputation risk in type 2 diabetes: the CANVAS Program","volume":"62","author":"Matthews","year":"2019","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.lpm.2023.104164_bib0090","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/dom.13115","article-title":"Risk of lower extremity amputations in people with type 2 diabetes mellitus treated with sodium-glucose co-transporter-2 inhibitors in the USA: a retrospective cohort study","volume":"20","author":"Yuan","year":"2018","journal-title":"Diabetes Obes Metab"},{"issue":"24","key":"10.1016\/j.lpm.2023.104164_bib0091","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","article-title":"Canagliflozin and renal outcomes in type 2 diabetes and nephropathy","volume":"380","author":"Perkovic","year":"2019","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.lpm.2023.104164_bib0092","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1111\/dom.14091","article-title":"The effect of canagliflozin on amputation risk in the CANVAS program and the CREDENCE trial","volume":"22","author":"Arnott","year":"2020","journal-title":"Diabetes Obes Metab"},{"issue":"14","key":"10.1016\/j.lpm.2023.104164_bib0093","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1161\/CIRCULATIONAHA.117.031227","article-title":"Cardiovascular outcomes and risks after initiation of a sodium glucose cotransporter 2 inhibitor: results from the EASEL population-based cohort study (evidence for cardiovascular outcomes with sodium glucose cotransporter 2 inhibitors in the real world)","volume":"137","author":"Udell","year":"2018","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.lpm.2023.104164_bib0094","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/S2213-8587(17)30257-7","article-title":"SGLT2 inhibitors and amputations in the US FDA adverse event reporting system","volume":"5","author":"Fadini","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"10.1016\/j.lpm.2023.104164_bib0095","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.2337\/dc17-1551","article-title":"Empagliflozin and assessment of lower-limb amputations in the EMPA-REG OUTCOME Trial","volume":"41","author":"Inzucchi","year":"2018","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.lpm.2023.104164_bib0096","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1161\/CIRCULATIONAHA.117.032031","article-title":"Cardiovascular outcomes and safety of empagliflozin in patients with type 2 diabetes mellitus and peripheral artery disease: a subanalysis of EMPA-REG OUTCOME","volume":"137","author":"Verma","year":"2018","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.lpm.2023.104164_bib0097","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1161\/CIRCULATIONAHA.119.044775","article-title":"Dapagliflozin and cardiac, kidney, and limb outcomes in patients with and without peripheral artery disease in DECLARE-TIMI 58","volume":"142","author":"Bonaca","year":"2020","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.lpm.2023.104164_bib0098","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1111\/dom.14159","article-title":"Sodium-glucose co-transporter-2 inhibitors and major adverse limb events: a trial-level meta-analysis including 51 713 individuals","volume":"22","author":"Huang","year":"2020","journal-title":"Diabetes Obes Metab"},{"issue":"9","key":"10.1016\/j.lpm.2023.104164_bib0099","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/eurheartj\/ehx095","article-title":"2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS)","volume":"39","author":"Aboyans","year":"2018","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.lpm.2023.104164_bib0100","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.jvs.2006.12.037","article-title":"Inter-society consensus for the management of peripheral arterial disease (TASC II)","volume":"45","author":"Norgren","year":"2007","journal-title":"J Vasc Surg"},{"issue":"Supplement_1","key":"10.1016\/j.lpm.2023.104164_bib0101","doi-asserted-by":"crossref","first-page":"S144","DOI":"10.2337\/dc22-S010","article-title":"10. Cardiovascular disease and risk management: standards of medical care in diabetes\u20142022","volume":"45","year":"2022","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.lpm.2023.104164_bib0102","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.jacc.2016.11.008","article-title":"2016 AHA\/ACC Guideline on the management of patients with lower extremity peripheral artery disease: executive summary","volume":"69","author":"Gerhard-Herman","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.lpm.2023.104164_bib0103","doi-asserted-by":"crossref","first-page":"e171","DOI":"10.1161\/CIR.0000000000001005","article-title":"Lower extremity peripheral artery disease: contemporary epidemiology, management gaps, and future directions: a scientific statement from the American Heart Association","volume":"144","author":"Criqui","year":"2021","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.lpm.2023.104164_bib0104","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"issue":"14","key":"10.1016\/j.lpm.2023.104164_bib0105","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1161\/CIRCULATIONAHA.117.032361","article-title":"Association of statin dose with amputation and survival in patients with peripheral artery disease","volume":"137","author":"Arya","year":"2018","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.lpm.2023.104164_bib0106","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.jacc.2013.09.073","article-title":"Association between statin medications and mortality, major adverse cardiovascular event, and amputation-free survival in patients with critical limb ischemia","volume":"63","author":"Westin","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"41","key":"10.1016\/j.lpm.2023.104164_bib0107","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1093\/eurheartj\/ehu080","article-title":"Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registry","volume":"35","author":"Kumbhani","year":"2014","journal-title":"Eur Heart J"},{"issue":"7","key":"10.1016\/j.lpm.2023.104164_bib0108","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1210\/jc.2016-3717","article-title":"Statin therapy reduces future risk of lower-limb amputation in patients with diabetes and peripheral artery disease","volume":"102","author":"Hsu","year":"2017","journal-title":"J Clinic Endocrinol Metabol"},{"issue":"2","key":"10.1016\/j.lpm.2023.104164_bib0109","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jvs.2018.07.089","article-title":"Statin use improves limb salvage after intervention for peripheral arterial disease","volume":"70","author":"Parmar","year":"2019","journal-title":"J Vasc Surg"},{"issue":"2","key":"10.1016\/j.lpm.2023.104164_bib0110","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1177\/1358863X19894055","article-title":"Statin therapy for reduction of cardiovascular and limb-related events in critical limb ischemia: a systematic review and meta-analysis","volume":"25","author":"Kokkinidis","year":"2020","journal-title":"Vasc Med"},{"issue":"4","key":"10.1016\/j.lpm.2023.104164_bib0111","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ejvs.2009.06.002","article-title":"Drug therapy for improving walking distance in intermittent claudication: a systematic review and meta-analysis of robust randomised controlled studies","volume":"38","author":"Momsen","year":"2009","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"5","key":"10.1016\/j.lpm.2023.104164_bib0112","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1161\/01.CIR.0000050380.64025.07","article-title":"Statin use and leg functioning in patients with and without lower-extremity peripheral arterial disease","volume":"107","author":"McDermott","year":"2003","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.lpm.2023.104164_bib0113","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.2337\/dc20-1533","article-title":"Fenofibrate use is associated with lower mortality and fewer cardiovascular events in patients with diabetes: results of 10,114 patients from the korean national health insurance service cohort","volume":"44","author":"Jo","year":"2021","journal-title":"Diabetes Care"},{"issue":"17","key":"10.1016\/j.lpm.2023.104164_bib0114","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1056\/NEJMoa1001282","article-title":"Effects of combination lipid therapy in type 2 diabetes mellitus","volume":"362","year":"2010","journal-title":"N Engl J Med"},{"issue":"9500","key":"10.1016\/j.lpm.2023.104164_bib0115","first-page":"1849","article-title":"Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial","volume":"366","year":"2005","journal-title":"Lancet North Am Ed"},{"issue":"9677","key":"10.1016\/j.lpm.2023.104164_bib0116","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1016\/S0140-6736(09)60698-X","article-title":"Effect of fenofibrate on amputation events in people with type 2 diabetes mellitus (FIELD study): a prespecified analysis of a randomised controlled trial","volume":"373","author":"Rajamani","year":"2009","journal-title":"Lancet North Am Ed"},{"issue":"1","key":"10.1016\/j.lpm.2023.104164_bib0117","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1812792","article-title":"Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia","volume":"380","author":"Bhatt","year":"2019","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.lpm.2023.104164_bib0118","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.006910","article-title":"Effect of PCSK9 inhibitors on clinical outcomes in patients with hypercholesterolemia: a meta-analysis of 35 randomized controlled trials","volume":"6","author":"Karatasakis","year":"2017","journal-title":"JAHA"},{"issue":"12","key":"10.1016\/j.lpm.2023.104164_bib0119","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/S2213-8587(17)30313-3","article-title":"Cardiovascular safety and efficacy of the PCSK9 inhibitor evolocumab in patients with and without diabetes and the effect of evolocumab on glycaemia and risk of new-onset diabetes: a prespecified analysis of the FOURIER randomised controlled trial","volume":"5","author":"Sabatine","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"4","key":"10.1016\/j.lpm.2023.104164_bib0120","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1161\/CIRCULATIONAHA.117.032235","article-title":"Low-density lipoprotein cholesterol lowering with evolocumab and outcomes in patients with peripheral artery disease: insights from the FOURIER trial (further cardiovascular outcomes research with PCSK9 inhibition in subjects with elevated risk)","volume":"137","author":"Bonaca","year":"2018","journal-title":"Circulation"},{"issue":"20","key":"10.1016\/j.lpm.2023.104164_bib0121","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1161\/CIRCULATIONAHA.120.046524","article-title":"Peripheral artery disease and venous thromboembolic events after acute coronary syndrome: role of Lipoprotein(a) and modification by alirocumab: prespecified analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial","volume":"141","author":"Schwartz","year":"2020","journal-title":"Circulation"},{"issue":"16","key":"10.1016\/j.lpm.2023.104164_bib0122","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1056\/NEJMoa1912387","article-title":"Two phase 3 trials of inclisiran in patients with elevated LDL cholesterol","volume":"382","author":"Ray","year":"2020","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1016\/j.lpm.2023.104164_bib0123","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1056\/NEJMoa1615758","article-title":"Inclisiran in patients at high cardiovascular risk with elevated LDL cholesterol","volume":"376","author":"Ray","year":"2017","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.lpm.2023.104164_bib0124","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1177\/2047487319865378","article-title":"2017 ACC\/AHA blood pressure classification and incident peripheral artery disease: the Atherosclerosis Risk in Communities (ARIC) Study","volume":"27","author":"Lu","year":"2020","journal-title":"Eur J Prev Cardiolog"},{"issue":"1","key":"10.1016\/j.lpm.2023.104164_bib0125","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1161\/HYPERTENSIONAHA.109.142240","article-title":"Outcomes among hypertensive patients with concomitant peripheral and coronary artery disease: findings from the INternational VErapamil-SR\/Trandolapril STudy","volume":"55","author":"Bavry","year":"2010","journal-title":"Hypertension"},{"issue":"17","key":"10.1016\/j.lpm.2023.104164_bib0126","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1161\/CIRCULATIONAHA.118.033348","article-title":"Association of blood pressure measurements with peripheral artery disease events: reanalysis of the ALLHAT Data","volume":"138","author":"Itoga","year":"2018","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.lpm.2023.104164_bib0127","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1161\/01.HYP.32.3.575","article-title":"Relation between coronary artery disease, aortic stiffness, and left ventricular structure in a population sample","volume":"32","author":"Gatzka","year":"1998","journal-title":"Hypertension"},{"issue":"7258","key":"10.1016\/j.lpm.2023.104164_bib0128","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1136\/bmj.321.7258.412","article-title":"Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study","volume":"321","author":"Adler","year":"2000","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.lpm.2023.104164_bib0129","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2337\/dc10-1420","article-title":"Blood pressure and cardiovascular disease risk in the veterans affairs diabetes trial","volume":"34","author":"Anderson","year":"2011","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.lpm.2023.104164_bib0130","article-title":"Treatment of hypertension in peripheral arterial disease","author":"Lane","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.lpm.2023.104164_bib0131","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1177\/1358863X15574321","article-title":"Angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use is associated with reduced major adverse cardiovascular events among patients with critical limb ischemia","volume":"20","author":"Armstrong","year":"2015","journal-title":"Vasc Med"},{"issue":"23","key":"10.1016\/j.lpm.2023.104164_bib0132","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1001\/jama.288.23.2981","article-title":"Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)","volume":"288","year":"2002","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.lpm.2023.104164_bib0133","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s00125-019-4835-z","article-title":"Lower limb events in individuals with type 2 diabetes: evidence for an increased risk associated with diuretic use","volume":"62","author":"Potier","year":"2019","journal-title":"Diabetologia"},{"issue":"12","key":"10.1016\/j.lpm.2023.104164_bib0134","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1056\/NEJMoa1904143","article-title":"Antithrombotic therapy for atrial fibrillation with stable coronary disease","volume":"381","author":"Yasuda","year":"2019","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.lpm.2023.104164_bib0135","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1161\/CIRCULATIONAHA.120.046048","article-title":"The COMPASS trial: net clinical benefit of low-dose rivaroxaban plus aspirin as compared with aspirin in patients with chronic vascular disease","volume":"142","author":"Steffel","year":"2020","journal-title":"Circulation"},{"issue":"21","key":"10.1016\/j.lpm.2023.104164_bib0136","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1056\/NEJMoa2000052","article-title":"Rivaroxaban in peripheral artery disease after revascularization","volume":"382","author":"Bonaca","year":"2020","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.lpm.2023.104164_bib0137","doi-asserted-by":"crossref","first-page":"e181","DOI":"10.1093\/eurjpc\/zwab128","article-title":"Low-dose rivaroxaban and aspirin among patients with peripheral artery disease: a meta-analysis of the COMPASS and VOYAGER trials","volume":"29","author":"Anand","year":"2022","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.lpm.2023.104164_bib0138","first-page":"pvac028","article-title":"Patients selected for dual pathway inhibition in clinical practice have similar characteristics and outcomes to those included in the COMPASS randomized trial: the XATOA Registry","author":"Fox","year":"2022","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"issue":"3","key":"10.1016\/j.lpm.2023.104164_bib0139","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1056\/NEJMoa065959","article-title":"Oral anticoagulant and antiplatelet therapy and peripheral arterial disease","volume":"357","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2023.104164_bib0140","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0140-6736(99)07199-8","article-title":"Efficacy of oral anticoagulants compared with aspirin after infrainguinal bypass surgery (the Dutch Bypass Oral anticoagulants or Aspirin study)","volume":"355","author":"Anand","year":"2000","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.lpm.2023.104164_bib0141","article-title":"Prostanoids for critical limb ischaemia","volume":"1","author":"Vietto","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"1S","key":"10.1016\/j.lpm.2023.104164_bib0142","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.ejvs.2019.05.006","article-title":"Global vascular guidelines on the management of chronic limb-threatening ischemia","volume":"58","author":"Conte","year":"2019","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"4","key":"10.1016\/j.lpm.2023.104164_bib0143","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.jvs.2017.06.119","article-title":"Outcomes after first-time lower extremity revascularization for chronic limb-threatening ischemia between patients with and without diabetes","volume":"67","author":"Darling","year":"2018","journal-title":"J Vasc Surg"},{"issue":"2","key":"10.1016\/j.lpm.2023.104164_bib0144","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.jvs.2017.11.081","article-title":"Treatment outcomes in diabetic patients with chronic limb-threatening ischemia","volume":"68","author":"Liang","year":"2018","journal-title":"J Vasc Surg"},{"issue":"3","key":"10.1016\/j.lpm.2023.104164_bib0145","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s00125-008-1226-2","article-title":"Complexity of factors related to outcome of neuropathic and neuroischaemic\/ischaemic diabetic foot ulcers: a cohort study","volume":"52","author":"Gershater","year":"2009","journal-title":"Diabetologia"},{"issue":"Suppl 1","key":"10.1016\/j.lpm.2023.104164_bib0146","doi-asserted-by":"crossref","first-page":"e3273","DOI":"10.1002\/dmrr.3273","article-title":"Guidelines on the classification of diabetic foot ulcers (IWGDF 2019)","volume":"36","author":"Monteiro-Soares","year":"2020","journal-title":"Diabetes Metab Res Rev"},{"issue":"12","key":"10.1016\/j.lpm.2023.104164_bib0147","doi-asserted-by":"crossref","first-page":"e132","DOI":"10.1093\/cid\/cis346","article-title":"2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections","volume":"54","author":"Lipsky","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.lpm.2023.104164_bib0148","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/wrr.12220","article-title":"Wound Healing Society. What's new in the literature: an update of new research since the original WHS diabetic foot ulcer guidelines in 2006","volume":"22","author":"Braun","year":"2014","journal-title":"Wound Repair Regen"},{"issue":"Suppl 1","key":"10.1016\/j.lpm.2023.104164_bib0149","doi-asserted-by":"crossref","first-page":"e3280","DOI":"10.1002\/dmrr.3280","article-title":"Guidelines on the diagnosis and treatment of foot infection in persons with diabetes (IWGDF 2019 update)","volume":"36","author":"Lipsky","year":"2020","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.lpm.2023.104164_bib0150","article-title":"Ubbink DT. Skin grafting and tissue replacement for treating foot ulcers in people with diabetes","volume":"2","author":"Santema","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"Suppl 1","key":"10.1016\/j.lpm.2023.104164_bib0151","doi-asserted-by":"crossref","first-page":"e3276","DOI":"10.1002\/dmrr.3276","article-title":"Guidelines on diagnosis, prognosis, and management of peripheral artery disease in patients with foot ulcers and diabetes (IWGDF 2019 update)","volume":"36","author":"Hinchliffe","year":"2020","journal-title":"Diabetes Metab Res Rev"},{"issue":"6","key":"10.1016\/j.lpm.2023.104164_bib0152","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1053\/j.jfas.2017.06.004","article-title":"Predictors of lower extremity amputation and reamputation associated with the diabetic foot","volume":"56","author":"Acar","year":"2017","journal-title":"J Foot Ankle Surg"},{"issue":"5","key":"10.1016\/j.lpm.2023.104164_bib0153","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s00125-008-0940-0","article-title":"Prediction of outcome in individuals with diabetic foot ulcers: focus on the differences between individuals with and without peripheral arterial disease. The EURODIALE Study","volume":"51","author":"Prompers","year":"2008","journal-title":"Diabetologia"},{"issue":"3 Suppl","key":"10.1016\/j.lpm.2023.104164_bib0154","doi-asserted-by":"crossref","first-page":"72S","DOI":"10.1016\/j.jvs.2010.06.011","article-title":"A step-wise approach for surgical management of diabetic foot infections","volume":"52","author":"Fisher","year":"2010","journal-title":"J Vasc Surg"},{"issue":"6","key":"10.1016\/j.lpm.2023.104164_bib0155","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1517\/14656566.2015.1021780","article-title":"In diabetic foot infections antibiotics are to treat infection, not to heal wounds","volume":"16","author":"Abbas","year":"2015","journal-title":"Expert Opin Pharmacother"},{"issue":"10","key":"10.1016\/j.lpm.2023.104164_bib0156","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD010318","article-title":"Negative pressure wound therapy for treating foot wounds in people with diabetes mellitus","author":"Dumville","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.lpm.2023.104164_bib0157","doi-asserted-by":"crossref","first-page":"533","DOI":"10.2147\/TCRM.S131193","article-title":"Evaluation of negative-pressure wound therapy for patients with diabetic foot ulcers: systematic review and meta-analysis","volume":"13","author":"Liu","year":"2017","journal-title":"Ther Clin Risk Manag"},{"issue":"Suppl 1","key":"10.1016\/j.lpm.2023.104164_bib0158","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/dmrr.2697","article-title":"IWGDF guidance on footwear and offloading interventions to prevent and heal foot ulcers in patients with diabetes","volume":"32","author":"Bus","year":"2016","journal-title":"Diabetes Metab Res Rev"},{"issue":"350","key":"10.1016\/j.lpm.2023.104164_bib0159","first-page":"149","article-title":"Long-term prognosis after healed amputation in patients with diabetes","author":"Larsson","year":"1998","journal-title":"Clin Orthop Relat Res"},{"issue":"3","key":"10.1016\/j.lpm.2023.104164_bib0160","first-page":"111","article-title":"Energy expenditure in below-knee amputees: correlation with stump length","volume":"55","author":"Gonzalez","year":"1974","journal-title":"Arch Phys Med Rehabil"},{"issue":"2","key":"10.1016\/j.lpm.2023.104164_bib0161","first-page":"67","article-title":"Energy expenditure of ambulation in patients with above-knee amputations","volume":"56","author":"Traugh","year":"1975","journal-title":"Arch Phys Med Rehabil"},{"issue":"S1","key":"10.1016\/j.lpm.2023.104164_bib0162","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/dmrr.2255","article-title":"Diagnosis and treatment of peripheral arterial disease in diabetic patients with a foot ulcer. A progress report of the International Working Group on the Diabetic Foot","volume":"28","author":"Schaper","year":"2012","journal-title":"Diabetes Metab Res Rev"},{"issue":"6","key":"10.1016\/j.lpm.2023.104164_bib0163","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/(SICI)1096-9136(199606)13:6<549::AID-DIA126>3.0.CO;2-R","article-title":"Predictors of transcutaneous oxygen tension in the lower limbs of diabetic subjects","volume":"13","author":"Boyko","year":"1996","journal-title":"Diabet Med"},{"issue":"1","key":"10.1016\/j.lpm.2023.104164_bib0164","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ejvs.2013.04.013","article-title":"Outcome of ischemic foot ulcer in diabetic patients who had no invasive vascular intervention","volume":"46","author":"Elgzyri","year":"2013","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"Suppl 1","key":"10.1016\/j.lpm.2023.104164_bib0165","doi-asserted-by":"crossref","first-page":"e3279","DOI":"10.1002\/dmrr.3279","article-title":"Effectiveness of revascularisation of the ulcerated foot in patients with diabetes and peripheral artery disease: a systematic review","volume":"36","author":"Forsythe","year":"2020","journal-title":"Diabetes Metab Res Rev"},{"issue":"6","key":"10.1016\/j.lpm.2023.104164_bib0166","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.2337\/diacare.26.6.1879","article-title":"Percent change in wound area of diabetic foot ulcers over a 4-week period is a robust predictor of complete healing in a 12-week prospective trial","volume":"26","author":"Sheehan","year":"2003","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.lpm.2023.104164_bib0167","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.ejvs.2014.06.041","article-title":"Early revascularization after admittance to a diabetic foot center affects the healing probability of ischemic foot ulcer in patients with diabetes","volume":"48","author":"Elgzyri","year":"2014","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"2","key":"10.1016\/j.lpm.2023.104164_bib0168","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ejvs.2016.10.023","article-title":"Analysis of the elective treatment process for critical limb ischaemia with tissue loss: diabetic patients require rapid revascularisation","volume":"53","author":"Noronen","year":"2017","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"2","key":"10.1016\/j.lpm.2023.104164_bib0169","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ejvs.2018.07.027","article-title":"Angiosome specific revascularisation: does the evidence support it?","volume":"57","author":"Stimpson","year":"2019","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"6","key":"10.1016\/j.lpm.2023.104164_bib0170","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1148\/rg.316115511","article-title":"Vascular imaging of the foot: the first step toward endovascular recanalization","volume":"31","author":"Manzi","year":"2011","journal-title":"Radiographics"},{"issue":"1","key":"10.1016\/j.lpm.2023.104164_bib0171","first-page":"3","article-title":"The challenging topic of diabetic foot revascularization: does the angiosome-guided angioplasty may improve outcome","volume":"53","author":"Alexandrescu","year":"2012","journal-title":"J Cardiovasc Surg (Torino)"},{"key":"10.1016\/j.lpm.2023.104164_bib0172","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.avsg.2018.01.061","article-title":"Diabetic foot limb salvage-a series of 809 attempts and predictors for endovascular limb salvage failure","volume":"49","author":"Lo","year":"2018","journal-title":"Ann Vasc Surg"},{"issue":"3","key":"10.1016\/j.lpm.2023.104164_bib0173","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ejvs.2011.12.001","article-title":"Factors influencing wound healing of critical ischaemic foot after bypass surgery: is the angiosome important in selecting bypass target artery?","volume":"43","author":"Azuma","year":"2012","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"4","key":"10.1016\/j.lpm.2023.104164_bib0174","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.avsg.2013.08.026","article-title":"Long-term outcomes of direct and indirect below-the-knee open revascularization based on the angiosome concept in diabetic patients with critical limb ischemia","volume":"28","author":"Lejay","year":"2014","journal-title":"Ann Vasc Surg"},{"issue":"4","key":"10.1016\/j.lpm.2023.104164_bib0175","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1007\/s00270-010-9881-3","article-title":"PTA of infrapopliteal arteries: long-term clinical follow-up and analysis of factors influencing clinical outcome","volume":"33","author":"Peregrin","year":"2010","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"9501","key":"10.1016\/j.lpm.2023.104164_bib0176","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/S0140-6736(05)67704-5","article-title":"Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial","volume":"366","author":"Adam","year":"2005","journal-title":"Lancet"},{"issue":"5 Suppl","key":"10.1016\/j.lpm.2023.104164_bib0177","doi-asserted-by":"crossref","first-page":"52S","DOI":"10.1016\/j.jvs.2010.01.077","article-title":"Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: a survival prediction model to facilitate clinical decision making","volume":"51","author":"Bradbury","year":"2010","journal-title":"J Vasc Surg"},{"issue":"5","key":"10.1016\/j.lpm.2023.104164_bib0178","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.ejvs.2018.02.015","article-title":"Editor's Choice - A comparison of clinical outcomes between primary bypass and secondary bypass after failed plain balloon angioplasty in the bypass versus angioplasty for severe ischaemia of the limb (BASIL) Trial","volume":"55","author":"Meecham","year":"2018","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"1","key":"10.1016\/j.lpm.2023.104164_bib0179","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1053\/j.semvascsurg.2015.01.003","article-title":"The BEST-CLI trial: a multidisciplinary effort to assess whether surgical or endovascular therapy is better for patients with critical limb ischemia","volume":"27","author":"Menard","year":"2014","journal-title":"Semin Vasc Surg"},{"key":"10.1016\/j.lpm.2023.104164_bib0180","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13063-015-1114-2","article-title":"Bypass versus angio plasty in severe ischaemia of the leg - 2 (BASIL-2) trial: study protocol for a randomised controlled trial","volume":"17","author":"Popplewell","year":"2016","journal-title":"Trials"},{"issue":"4","key":"10.1016\/j.lpm.2023.104164_bib0181","first-page":"611","volume":"86","author":"Jaff","year":"2015","journal-title":"Catheter Cardiovasc Interv"},{"issue":"15","key":"10.1016\/j.lpm.2023.104164_bib0182","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/j.jacc.2014.06.1198","article-title":"Drug-eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12-month results from the IN.PACT DEEP randomized trial","volume":"64","author":"Zeller","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.lpm.2023.104164_bib0183","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002938","article-title":"Critical limb ischemia: current trends and future directions","volume":"5","author":"Teraa","year":"2016","journal-title":"J Am Heart Assoc"},{"issue":"Suppl 1","key":"10.1016\/j.lpm.2023.104164_bib0184","doi-asserted-by":"crossref","first-page":"e3266","DOI":"10.1002\/dmrr.3266","article-title":"Practical Guidelines on the prevention and management of diabetic foot disease (IWGDF 2019 update)","volume":"36","author":"Schaper","year":"2020","journal-title":"Diabetes Metab Res Rev"},{"issue":"Suppl 1","key":"10.1016\/j.lpm.2023.104164_bib0185","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/dmrr.2758","article-title":"Integrating palliative care with usual care of diabetic foot wounds","volume":"32","author":"Dunning","year":"2016","journal-title":"Diabetes Metab Res Rev"},{"issue":"4","key":"10.1016\/j.lpm.2023.104164_bib0186","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.jvs.2012.04.046","article-title":"Supervised walking therapy in patients with intermittent claudication","volume":"56","author":"Fakhry","year":"2012","journal-title":"J Vasc Surg"},{"issue":"2","key":"10.1016\/j.lpm.2023.104164_bib0187","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/jama.2008.962","article-title":"Treadmill exercise and resistance training in patients with peripheral arterial disease with and without intermittent claudication: a randomized controlled trial","volume":"301","author":"McDermott","year":"2009","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.lpm.2023.104164_bib0188","doi-asserted-by":"crossref","first-page":"2S","DOI":"10.1016\/j.jvs.2014.12.009","article-title":"Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: management of asymptomatic disease and claudication","volume":"61","author":"Conte","year":"2015","journal-title":"J Vasc Surg"},{"issue":"4","key":"10.1016\/j.lpm.2023.104164_bib0189","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1161\/CIR.0000000000000623","article-title":"Optimal exercise programs for patients with peripheral artery disease: a scientific statement from the american heart association","volume":"139","author":"Treat-Jacobson","year":"2019","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.lpm.2023.104164_bib0190","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1161\/CIRCULATIONAHA.111.075770","article-title":"Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six-month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study","volume":"125","author":"Murphy","year":"2012","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.lpm.2023.104164_bib0191","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001107","article-title":"Step-monitored home exercise improves ambulation, vascular function, and inflammation in symptomatic patients with peripheral artery disease: a randomized controlled trial","volume":"3","author":"Gardner","year":"2014","journal-title":"JAHA"},{"issue":"1","key":"10.1016\/j.lpm.2023.104164_bib0192","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/jama.2013.7231","article-title":"Home-based walking exercise intervention in peripheral artery disease: a randomized clinical trial","volume":"310","author":"McDermott","year":"2013","journal-title":"JAMA"},{"issue":"13","key":"10.1016\/j.lpm.2023.104164_bib0193","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1001\/jama.2021.2536","article-title":"Effect of low-intensity vs high-intensity home-based walking exercise on walk distance in patients with peripheral artery disease: the LITE Randomized Clinical Trial","volume":"325","author":"McDermott","year":"2021","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.lpm.2023.104164_bib0194","article-title":"Supervised exercise therapy versus home-based exercise therapy versus walking advice for intermittent claudication","volume":"4","author":"Hageman","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"10.1016\/j.lpm.2023.104164_bib0195","doi-asserted-by":"crossref","first-page":"7961","DOI":"10.3390\/ijerph110807961","article-title":"Effectiveness of a new exercise program after lower limb arterial blood flow surgery in patients with peripheral arterial disease: a randomized clinical trial","volume":"11","author":"Jakubsevi\u010dien\u0117","year":"2014","journal-title":"IJERPH"},{"issue":"12","key":"10.1016\/j.lpm.2023.104164_bib0196","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000990.pub4","article-title":"Exercise for intermittent claudication","volume":"12","author":"Lane","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1016\/j.lpm.2023.104164_bib0197","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJMoa1212914","article-title":"Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes","volume":"369","year":"2013","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.lpm.2023.104164_bib0198","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1177\/1358863X19867393","article-title":"Healthy diet and fiber intake are associated with decreased risk of incident symptomatic peripheral artery disease \u2013 a prospective cohort study","volume":"24","author":"Kulezic","year":"2019","journal-title":"Vasc Med"},{"issue":"3","key":"10.1016\/j.lpm.2023.104164_bib0199","doi-asserted-by":"crossref","first-page":"651","DOI":"10.3945\/ajcn.116.137497","article-title":"Dietary intake and peripheral arterial disease incidence in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study","volume":"105","author":"Ogilvie","year":"2017","journal-title":"Am J Clin Nutr"},{"issue":"4","key":"10.1016\/j.lpm.2023.104164_bib0200","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1001\/jama.2013.280618","article-title":"Association of mediterranean diet with peripheral artery disease: the PREDIMED Randomized Trial","volume":"311","author":"Ruiz-Canela","year":"2014","journal-title":"JAMA"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498223000015?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498223000015?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:10:04Z","timestamp":1760105404000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498223000015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":200,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S0755498223000015"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2023.104164","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lower-limb peripheral arterial disease and amputations in people with diabetes: Risk factors, prognostic value and management","name":"articletitle","label":"Article Title"},{"value":"La Presse M\u00e9dicale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2023.104164","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104164"}}